FDA Mulls Study On Yeast Infection Drug's Miscarriage Risk
The U.S. Food and Drug Administration said Tuesday it is reviewing the results of a European study that found pregnant women face a possible increased risk of miscarriage if they take...To view the full article, register now.
Already a subscriber? Click here to view full article